Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control To investigate efficacy, safety and tolerability of BI 1356 versus placebo

• Country Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
• organs None
• Specialty None

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder The purpose of the study is to assess whether treatment with SR58611A can prevent relapse of depressive symptoms in patients with major depressive disorder. Relapse will be assessed using ...

• Country Argentina, Bulgaria, Croatia, Czech Republic, Finland, France, Mexico, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa
• organs None
• Specialty None

A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients The primary objective of this study is to evaluate the effects of aflibercept on the QTc interval in cancer patients. Secondary objectives are to evaluate the effects of aflibercept on ot...

• Country Belgium, Denmark, Germany, Italy, Romania, Turkey, United States
• organs None
• Specialty None

Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy The study will have two treatment groups, evaluating two Degarelix doses. First dose is the initial dose followed by a maintenance dose given every three months. The initial dose given to ...

• Country Canada, Czech Republic, Hungary, Romania, United States
• organs None
• Specialty None

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate This study is a Phase 2 randomized, double-blind, double-dummy, active- and placebo-controlled, parallel-group study designed to assess the safety, tolerability, efficacy, pharmacokinetics...

• Country Australia, Bulgaria, Czech Republic, France, Germany, Hungary, Italy, Latvia, New Zealand, Poland, Romania, Spain, United States
• organs None
• Specialty None

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease The purpose of this study is to determine the long term safety and clinical utility of IPX066 in subjects with Parkinson's Disease.

• Country Canada, Estonia, Germany, Latvia, Lithuania, Poland, Romania, Spain, Ukraine, United States
• organs None
• Specialty None

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.

• Country Guatemala, Romania, United States
• organs None
• Specialty None

Creon in HIV Patients With Steatorrhea The study investigates the effect of pancreatic enzymes on steatorrhea in HIV patients.

• Country Romania
• organs None
• Specialty None

Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria Study of the efficacy and safety of aliskiren when added to losartan and optimal antihypertensive therapy in patients with hypertension, type 2 diabetes, and kidney disorders to monitor im...

• Country Canada, Denmark, France, Germany, Greece, Italy, Netherlands, Romania, Russian Federation, Spain, United Kingdom, United States
• organs None
• Specialty None

Open-Label Tolvaptan Study in Subjects With ADPKD To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from baseline (from trial 156-04-251) in total kidney volume (TKV) and renal function.

• Country Argentina, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, United Kingdom, United States
• organs None
• Specialty None